Part 1: Clinical Case Study Compendium:

The impact of gilteritinib in daily practice as salvage treatment and as bridging therapy. Real-World ...

Accessible only to healthcare professionals authorized to prescribe

Part 2: Clinical Case Study Compendium:

The impact of gilteritinib in daily practice after intensive chemotherapy and following an ..

Video of case report 4:

In this interview Dr. A. de Voeght (Sart Tilman-CHU Liège, Belgium), discusses his experiences with gilteritinib following an allo-HSCT².

Intended for: practitioners hematology
Why: up-to-date knowledge TKI³ related target therapy
When: Watch now
Duration: 4 minutes

1: FMS-like Tyrosine Kinase Inhibitor 3-Acute Myeloid Leukemia; 2: Hematopoietic Stam Cell Transplantation; 3: Tyrosine Kinase Inhibitor.

MAT-BE-XOS-2026-00009 MAR 2026

AML: Acute Myeloid Leukemia